{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:14:10Z","timestamp":1793330050946,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13477-3","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T21:20:38Z","timestamp":1754083238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification of palmitoylated biomarkers in non-alcoholic fatty liver disease via integrated bioinformatics analysis and machine learning"],"prefix":"10.1038","volume":"15","author":[{"given":"Zheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"13477_CR1","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi, Z. et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 69, 2672\u20132682 (2019).","journal-title":"Hepatology"},{"key":"13477_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong, V. W. et al. Changing epidemiology, global trends and implications for outcomes of NAFLD. J. Hepatol. 79, 842\u2013852 (2023).","journal-title":"J. Hepatol."},{"key":"13477_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"13477_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L. et al. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908\u2013922 (2018).","journal-title":"Nat. Med."},{"key":"13477_CR5","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W. & Rinella, M. Non-alcoholic fatty liver disease. Lancet 397, 2212\u20132224 (2021).","journal-title":"Lancet"},{"key":"13477_CR6","doi-asserted-by":"crossref","unstructured":"Fernando, D. H. et al. Development and progression of non-alcoholic fatty liver disease: the role of advanced glycation end products. Int. J. Mol. Sci. 20, 5037 (2019).","DOI":"10.3390\/ijms20205037"},{"key":"13477_CR7","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537\u20132564 (2021).","journal-title":"Cell"},{"key":"13477_CR8","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","volume":"119","author":"C Grander","year":"2023","unstructured":"Grander, C., Grabherr, F. & Tilg, H. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovasc. Res. 119, 1787\u20131798 (2023).","journal-title":"Cardiovasc. Res."},{"key":"13477_CR9","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","volume":"65","author":"R Pais","year":"2016","unstructured":"Pais, R. et al. NAFLD and liver transplantation: current burden and expected challenges. J. Hepatol. 65, 1245\u20131257 (2016).","journal-title":"J. Hepatol."},{"key":"13477_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41467-025-56344-5","volume":"16","author":"B Huang","year":"2025","unstructured":"Huang, B. et al. Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis. Nat. Commun. 16, 867 (2025).","journal-title":"Nat. Commun."},{"key":"13477_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41580-024-00700-8","volume":"25","author":"SM F","year":"2024","unstructured":"F, S. M. et al. Mechanisms and functions of protein S-acylation. Nat. Rev. Mol. Cell. Biol. 25, 488\u2013509 (2024).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"13477_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-024-01759-7","volume":"9","author":"Y Yuan","year":"2024","unstructured":"Yuan, Y. et al. Protein lipidation in health and disease: molecular basis, physiological function and pathological implication. Signal. Transduct. Target. Ther. 9, 60 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"13477_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/ATVBAHA.113.302848","volume":"34","author":"X Wei","year":"2014","unstructured":"Wei, X., Song, H. & Semenkovich, C. F. Insulin-regulated protein palmitoylation impacts endothelial cell function. Arterioscler. Thromb. Vasc Biol. 34, 346\u2013354 (2014).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"13477_CR14","doi-asserted-by":"publisher","unstructured":"Wang, Y. et al. Protein palmitoylation in hepatic diseases: functional insights and therapeutic strategies. J. Adv. Res. https:\/\/doi.org\/10.1016\/j.jare.2024.12.041 (2024).","DOI":"10.1016\/j.jare.2024.12.041"},{"key":"13477_CR15","doi-asserted-by":"publisher","first-page":"113025","DOI":"10.1016\/j.intimp.2024.113025","volume":"142","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Therapeutic potential of palmitoleic acid in non-alcoholic fatty liver disease: targeting ferroptosis and lipid metabolism disorders. Int. Immunopharmacol. 142, 113025 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"13477_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41420-025-02312-3","volume":"11","author":"Y He","year":"2025","unstructured":"He, Y. et al. Impaired rela signaling and lipid metabolism dysregulation in hepatocytes: driving forces in the progression of metabolic dysfunction-associated steatotic liver disease. Cell. Death Discov. 11, 49 (2025).","journal-title":"Cell. Death Discov"},{"key":"13477_CR17","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.3390\/nu7053483","volume":"7","author":"H Tian","year":"2015","unstructured":"Tian, H. et al. MiRNA-194 regulates palmitic Acid-Induced Toll-Like receptor 4 inflammatory responses in THP-1 cells. Nutrients 7, 3483\u20133496 (2015).","journal-title":"Nutrients"},{"key":"13477_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","volume":"81","author":"KR LeFort","year":"2024","unstructured":"LeFort, K. R., Rungratanawanich, W. & Song, B. J. Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. Cell. Mol. Life Sci. 81, 34 (2024).","journal-title":"Cell. Mol. Life Sci."},{"key":"13477_CR19","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M. et al. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"key":"13477_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"13477_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12967-025-06122-0","volume":"23","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. Exploring TNFR1: from discovery to targeted therapy development. J. Transl Med. 23, 71 (2025).","journal-title":"J. Transl Med."},{"key":"13477_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ncpgasthep0055","volume":"1","author":"SL Friedman","year":"2004","unstructured":"Friedman, S. L. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat. Clin. Pract. Gastroenterol. Hepatol. 1, 98\u2013105 (2004).","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"13477_CR23","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI43378","volume":"121","author":"WL Holland","year":"2011","unstructured":"Holland, W. L. et al. Lipid-induced insulin resistance mediated by the Proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121, 1858\u20131870 (2011).","journal-title":"J. Clin. Invest."},{"key":"13477_CR24","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1038\/s41467-024-50341-w","volume":"15","author":"M Hering","year":"2024","unstructured":"Hering, M. et al. Sphinganine recruits TLR4 adaptors in macrophages and promotes inflammation in murine models of sepsis and melanoma. Nat. Commun. 15, 6067 (2024).","journal-title":"Nat. Commun."},{"key":"13477_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125\u2013172 (2008).","journal-title":"Physiol. Rev."},{"key":"13477_CR26","doi-asserted-by":"publisher","first-page":"114472","DOI":"10.1016\/j.biopha.2023.114472","volume":"161","author":"L Shan","year":"2023","unstructured":"Shan, L. et al. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis. Biomed. Pharmacother. 161, 114472 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"13477_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10565-024-09956-4","volume":"41","author":"LN Rutt","year":"2024","unstructured":"Rutt, L. N., Orlicky, D. J. & McCullough, R. L. Investigating the role of Wnt3a and Wnt5a as critical factors of hepatic stellate cell activation in acute toxicant-induced liver injury. Cell. Biol. Toxicol. 41, 5 (2024).","journal-title":"Cell. Biol. Toxicol."},{"key":"13477_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1146\/annurev.bi.64.070195.003445","volume":"64","author":"CW Carreras","year":"1995","unstructured":"Carreras, C. W. & Santi, D. V. The catalytic mechanism and structure of thymidylate synthase. Annu. Rev. Biochem. 64, 721\u2013762 (1995).","journal-title":"Annu. Rev. Biochem."},{"key":"13477_CR29","doi-asserted-by":"publisher","first-page":"1442238","DOI":"10.3389\/fcvm.2024.1442238","volume":"11","author":"W Tang","year":"2024","unstructured":"Tang, W. et al. DEPDC1B, CDCA2, APOBEC3B, and TYMS are potential hub genes and therapeutic targets for diagnosing Dialysis patients with heart failure. Front. Cardiovasc. Med. 11, 1442238 (2024).","journal-title":"Front. Cardiovasc. Med."},{"key":"13477_CR30","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1038\/s41388-023-02694-7","volume":"42","author":"MV Guijarro","year":"2023","unstructured":"Guijarro, M. V. et al. TYMS promotes genomic instability and tumor progression in Ink4a\/Arf null background. Oncogene 42, 1926\u20131939 (2023).","journal-title":"Oncogene"},{"key":"13477_CR31","first-page":"2582","volume":"125","author":"J Tang","year":"2012","unstructured":"Tang, J. et al. Thymidylate synthase genetic polymorphisms and cancer risk: a meta-analysis of 37 case-control studies. Chin. Med. J. (Engl). 125, 2582\u20132588 (2012).","journal-title":"Chin. Med. J. (Engl)"},{"key":"13477_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12935-021-02372-2","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma. Cancer Cell. Int. 22, 47 (2022).","journal-title":"Cancer Cell. Int."},{"key":"13477_CR33","doi-asserted-by":"publisher","first-page":"101042831769119","DOI":"10.1177\/1010428317691190","volume":"39","author":"G Velasco-Loyden","year":"2017","unstructured":"Velasco-Loyden, G. et al. Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats. Tumour Biol. 39, 1010428317691190 (2017).","journal-title":"Tumour Biol."},{"key":"13477_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41569-022-00718-5","volume":"19","author":"I Akoumianakis","year":"2022","unstructured":"Akoumianakis, I., Polkinghorne, M. & Antoniades, C. Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications. Nat. Rev. Cardiol. 19, 783\u2013797 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"13477_CR35","doi-asserted-by":"publisher","first-page":"156381","DOI":"10.1016\/j.cyto.2023.156381","volume":"172","author":"Y Huang","year":"2023","unstructured":"Huang, Y. et al. Wnt5a: A promising therapeutic target for inflammation, especially rheumatoid arthritis. Cytokine 172, 156381 (2023).","journal-title":"Cytokine"},{"key":"13477_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/imm.13882","volume":"174","author":"XH Yu","year":"2025","unstructured":"Yu, X. H. et al. The role of Wnt5a in inflammatory diseases. Immunology 174, 203\u2013212 (2025).","journal-title":"Immunology"},{"key":"13477_CR37","doi-asserted-by":"crossref","unstructured":"Koutaki, D. et al. The emerging role of Sfrp5 and Wnt5a in the pathogenesis of obesity: implications for a healthy diet and lifestyle. Nutrients. 13, 2459 (2021).","DOI":"10.3390\/nu13072459"},{"key":"13477_CR38","doi-asserted-by":"crossref","unstructured":"Akoumianakis, I. et al. Adipose tissue-derived WNT5A regulates vascular redox signaling in obesity via USP17\/RAC1-mediated activation of NADPH oxidases. Sci. Transl Med. 11, eaav5055 (2019).","DOI":"10.1126\/scitranslmed.aav5055"},{"key":"13477_CR39","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/liv.12757","volume":"35","author":"N Chatani","year":"2015","unstructured":"Chatani, N. et al. Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. Liver Int. 35, 2017\u20132026 (2015).","journal-title":"Liver Int."},{"key":"13477_CR40","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3748\/wjg.v18.i15.1745","volume":"18","author":"WJ Xiong","year":"2012","unstructured":"Xiong, W. J. et al. Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays. World J. Gastroenterol. 18, 1745\u20131752 (2012).","journal-title":"World J. Gastroenterol."},{"key":"13477_CR41","doi-asserted-by":"publisher","first-page":"e0142794","DOI":"10.1371\/journal.pone.0142794","volume":"10","author":"L Corbett","year":"2015","unstructured":"Corbett, L., Mann, J. & Mann, D. A. Non-Canonical Wnt predominates in activated rat hepatic stellate cells, influencing HSC survival and paracrine stimulation of Kupffer cells. PLoS One. 10, e0142794 (2015).","journal-title":"PLoS One"},{"key":"13477_CR42","doi-asserted-by":"publisher","first-page":"G219","DOI":"10.1152\/ajpgi.00160.2016","volume":"312","author":"L Beljaars","year":"2017","unstructured":"Beljaars, L. et al. WNT-5A regulates TGF-\u03b2-related activities in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 312, G219\u2013g227 (2017).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"13477_CR43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s13018-024-05232-7","volume":"19","author":"H Su","year":"2024","unstructured":"Su, H. et al. ZFP36, an RNA-binding protein promotes hBMSCs osteogenic differentiation via binding with JUN. J. Orthop. Surg. Res. 19, 758 (2024).","journal-title":"J. Orthop. Surg. Res."},{"key":"13477_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2024.104859","volume":"403\u2013404","author":"Y Uehara","year":"2024","unstructured":"Uehara, Y. et al. ZFP36 family expression is suppressed by Th2 cells in asthma, leading to enhanced synthesis of inflammatory cytokines and cell surface molecules. Cell. Immunol. 403\u2013404:104859. (2024).","journal-title":"Cell. Immunol."},{"key":"13477_CR45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/postmj\/qgae146","volume":"101","author":"Z Peilin","year":"2025","unstructured":"Peilin, Z. et al. Inflammatory cytokines, metabolites, and rheumatoid arthritis. Postgrad. Med. J. 101, 313\u2013320 (2025).","journal-title":"Postgrad. Med. J."},{"key":"13477_CR46","doi-asserted-by":"publisher","first-page":"156131","DOI":"10.1016\/j.metabol.2024.156131","volume":"164","author":"Y Hu","year":"2025","unstructured":"Hu, Y. et al. Adipose ZFP36 protects against diet-induced obesity and insulin resistance. Metabolism 164, 156131 (2025).","journal-title":"Metabolism"},{"key":"13477_CR47","doi-asserted-by":"publisher","first-page":"112411","DOI":"10.1016\/j.celrep.2023.112411","volume":"42","author":"AC Cicchetto","year":"2023","unstructured":"Cicchetto, A. C. et al. ZFP36-mediated mRNA decay regulates metabolism. Cell. Rep. 42, 112411 (2023).","journal-title":"Cell. Rep."},{"key":"13477_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng, J. et al. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal. Transduct. Target. Ther. 10, 35 (2025).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"13477_CR49","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41419-024-06964-4","volume":"15","author":"S Yadav","year":"2024","unstructured":"Yadav, S. et al. Regulation of Zfp36 by ISGF3 and MK2 restricts the expression of inflammatory cytokines during necroptosis stimulation. Cell. Death Dis. 15, 574 (2024).","journal-title":"Cell. Death Dis."},{"key":"13477_CR50","doi-asserted-by":"publisher","first-page":"113929","DOI":"10.1016\/j.intimp.2024.113929","volume":"147","author":"JY Cheng","year":"2025","unstructured":"Cheng, J. Y. et al. MIF\/CD74 axis in hepatic stellate cells mediates HBV-related liver fibrosis. Int. Immunopharmacol. 147, 113929 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"13477_CR51","doi-asserted-by":"publisher","first-page":"108285","DOI":"10.1016\/j.jbc.2025.108285","volume":"301","author":"Y Guo","year":"2025","unstructured":"Guo, Y. et al. Amyloid precursor protein promotes MASH progression by upregulating death receptor 6-mediated hepatocyte apoptosis. J. Biol. Chem. 301, 108285 (2025).","journal-title":"J. Biol. Chem."},{"key":"13477_CR52","doi-asserted-by":"publisher","first-page":"1454980","DOI":"10.3389\/fmed.2024.1454980","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Signaling pathways that activate hepatic stellate cells during liver fibrosis. Front. Med. (Lausanne). 11, 1454980 (2024).","journal-title":"Front. Med. (Lausanne)"},{"key":"13477_CR53","doi-asserted-by":"crossref","unstructured":"Li, H. et al. Macrophages, chronic inflammation, and insulin resistance. Cells 11, 3001 (2022).","DOI":"10.3390\/cells11193001"},{"key":"13477_CR54","doi-asserted-by":"publisher","first-page":"113051","DOI":"10.1016\/j.intimp.2024.113051","volume":"142","author":"W Wu","year":"2024","unstructured":"Wu, W. et al. Neutrophil PPIF exacerbates lung ischemia-reperfusion injury after lung transplantation by promoting calcium overload-induced neutrophil extracellular traps formation. Int. Immunopharmacol. 142, 113051 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"13477_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12951-025-03195-3","volume":"23","author":"H Li","year":"2025","unstructured":"Li, H. et al. Innovative nanoparticle-based approaches for modulating neutrophil extracellular traps in diseases: from mechanisms to therapeutics. J. Nanobiotechnol. 23, 88 (2025).","journal-title":"J. Nanobiotechnol."},{"key":"13477_CR56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/bib\/bbt085","volume":"16","author":"HM Zhang","year":"2015","unstructured":"Zhang, H. M. et al. Transcription factor and MicroRNA co-regulatory loops: important regulatory motifs in biological processes and diseases. Brief. Bioinform. 16, 45\u201358 (2015).","journal-title":"Brief. Bioinform"},{"key":"13477_CR57","doi-asserted-by":"publisher","first-page":"8980","DOI":"10.1038\/s41598-021-88518-8","volume":"11","author":"LAP Simino","year":"2021","unstructured":"Simino, L. A. P. et al. MicroRNA Let-7 targets AMPK and impairs hepatic lipid metabolism in offspring of maternal obese pregnancies. Sci. Rep. 11, 8980 (2021).","journal-title":"Sci. Rep."},{"key":"13477_CR58","doi-asserted-by":"publisher","first-page":"101828","DOI":"10.1016\/j.molmet.2023.101828","volume":"78","author":"J Song","year":"2023","unstructured":"Song, J. et al. Let-7 suppresses liver fibrosis by inhibiting hepatocyte apoptosis and TGF-\u03b2 production. Mol. Metab. 78, 101828 (2023).","journal-title":"Mol. Metab."},{"key":"13477_CR59","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1038\/s41598-017-09702-3","volume":"7","author":"PJ Hsiao","year":"2017","unstructured":"Hsiao, P. J. et al. Pioglitazone enhances cytosolic lipolysis, \u03b2-oxidation and autophagy to ameliorate hepatic steatosis. Sci. Rep. 7, 9030 (2017).","journal-title":"Sci. Rep."},{"key":"13477_CR60","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1111\/bph.14434","volume":"175","author":"H Yang","year":"2018","unstructured":"Yang, H. et al. Metabolomic and lipidomic analysis of the effect of Pioglitazone on hepatic steatosis in a rat model of obese type 2 diabetes. Br. J. Pharmacol. 175, 3610\u20133625 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"13477_CR61","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1039\/D4FO00215F","volume":"15","author":"A Yang","year":"2024","unstructured":"Yang, A. et al. Vitamin D(3) exacerbates steatosis while calcipotriol inhibits inflammation in non-alcoholic fatty liver disease in Sod1 knockout mice: a comparative study of two forms of vitamin D. Food Funct. 15, 4614\u20134626 (2024).","journal-title":"Food Funct."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13477-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13477-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13477-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:13:05Z","timestamp":1757337185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13477-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13477"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13477-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28177"}}